L
3.86
-0.04 (-1.03%)
| Previous Close | 3.90 |
| Open | 4.04 |
| Volume | 5,050,997 |
| Avg. Volume (3M) | 2,175,061 |
| Market Cap | 1,516,617,088 |
| Price / Earnings (Forward) | 44.44 |
| Price / Sales | 1.56 |
| Price / Book | 1.41 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2025 |
| Profit Margin | -2.78% |
| Operating Margin (TTM) | 0.48% |
| Diluted EPS (TTM) | -0.090 |
| Quarterly Revenue Growth (YOY) | 10.80% |
| Total Debt/Equity (MRQ) | 33.09% |
| Current Ratio (MRQ) | 1.47 |
| Operating Cash Flow (TTM) | 126.01 M |
| Levered Free Cash Flow (TTM) | 113.77 M |
| Return on Assets (TTM) | -0.33% |
| Return on Equity (TTM) | -2.47% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | LifeStance Health Group, Inc. | Bullish | Bullish |
AIStockmoo Score
1.6
| Analyst Consensus | 3.5 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 1.63 |
|
LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 8.22% |
| % Held by Institutions | 93.24% |
| 52 Weeks Range | ||
| Median | 9.00 (133.16%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 08 Aug 2025 | 9.00 (133.16%) | Buy | 4.37 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 16 Oct 2025 | Announcement | LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025 |
| 26 Aug 2025 | Announcement | LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference |
| 22 Aug 2025 | Announcement | Sarah Personette Appointed to LifeStance Board of Directors |
| 07 Aug 2025 | Announcement | LifeStance Reports Second Quarter 2025 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |